Trials / Completed
CompletedNCT05221346
Effect of Oleactiv® on LDL Oxidability
Effect of Oleactiv® on LDL Oxidability in Volunteers With Moderate Hypercholesterolemia - a Controlled, Randomized, Double-blind Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Institut Pasteur de Lille · Academic / Other
- Sex
- Male
- Age
- 40 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Oleactiv® have previously demonstrated beneficial effects in an animal model of diet-induced atherosclerosis. After a 12-week supplementation, a substantial reduction of aortic fatty streak area has been observed. Also, Oleactiv®-supplemented hamsters displayed significant decrease of both non-HDL-cholesterol and triglycerides levels. Also, phenolic compounds from Oleactiv® demonstrated that increase of cholesterol efflux capacity (CEC) is one of the mechanisms that may explain preventive effect on atheroma development. These effects observed in animals will thus be investigated in human. The main hypothesis of the present study is that phenolic compounds from Oleactiv® may improve LDL oxidability in volunteers with moderate hypercholesterolemia after 3 weeks of consumption.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Plant food supplement | Food supplements are consumed during 3 weeks by hypercholesterolemic volunteers |
| DIETARY_SUPPLEMENT | Maltodextrin | Food supplements are consumed during 3 weeks by hypercholesterolemic volunteers |
Timeline
- Start date
- 2021-12-13
- Primary completion
- 2022-10-11
- Completion
- 2022-10-11
- First posted
- 2022-02-03
- Last updated
- 2022-12-07
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05221346. Inclusion in this directory is not an endorsement.